Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
TAVR-Prehab
1 other identifier
interventional
35
1 country
1
Brief Summary
In this pilot study, investigators aim to identify patients undergoing TAVR who are at elevated risk for adverse clinical events due to decreased exertional capacity and physical deconditioning. Investigators aim to determine if monitored pre-procedural physical therapy is safe in these patients. Lastly, investigators aim to assess the efficacy of prehabilitation
- 1.to improve physical functioning by the time of TAVR and to sustain benefit through 30 days post-procedure; and
- 2.to determine its effect on post-procedural length-of-stay, clinical outcomes, and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 17, 2016
CompletedFirst Submitted
Initial submission to the registry
March 7, 2017
CompletedFirst Posted
Study publicly available on registry
April 11, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2021
CompletedJune 9, 2023
June 1, 2023
4 years
March 7, 2017
June 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional exercise capacity - Change in 6 Minute Walk Test (6MWT)
Measure: Does prehabilitation improve the subject's functional exercise capacity from first PT assessment to pre-procedure assessment and first PT assessment to one month post-procedure, as measured by the 6MWT?
One month post procedure
Secondary Outcomes (7)
Mobility - Timed Up and Go Test (TUG)
One month
Balance - Four Square Step Test (FSST)
One month
Discharge Disposition
24-48 hours post procedure
Length of stay in the ICU
TAVR procedure admission
Total hospital length of stay
TAVR procedure admission
- +2 more secondary outcomes
Study Arms (2)
Pre-procedure standard of care
NO INTERVENTIONNo prehab prior to TAVR.
Prehab prior to TAVR procedure.
ACTIVE COMPARATORIndividuals participate in prehabilitation prior to TAVR.
Interventions
Eight - Twelve visits to physical therapy prior to their TAVR procedure.
Eligibility Criteria
You may qualify if:
- Subject must be ambulatory (with or without an assist device)
- Subject has severe aortic stenosis and is felt an appropriate candidate for TAVR by the Heart Team.
- Subject requires 6.0 seconds or longer to complete a 15ft walk test
- Subject must be able to move between sitting and standing without assistance from another person.
- Subject has adequate iliac and femoral arterial anatomy to allow for TAVR via transfemoral access
- Subject is 18 years of age or greater
- Subject is willing to give consent and participate in the study
You may not qualify if:
- Subject is incapable of following instructions
- Subject is unable to meet the minimum required physical therapy visits
- Subject has other medical conditions rendering it unsafe, in the opinion of the Principal Investigator and physical therapy staff, to perform a 6 Minute Walk Test or physical therapy conditioning prior to TAVR
- Subject has significant severe un-revascularized epicardial coronary disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- WellSpan Healthlead
Study Sites (1)
Wellspan York Hospital
York, Pennsylvania, 17403, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
James Harvey, MD
Wellspan York Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 7, 2017
First Posted
April 11, 2017
Study Start
August 17, 2016
Primary Completion
August 9, 2020
Study Completion
April 30, 2021
Last Updated
June 9, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Immediately following publication. No End Date
- Access Criteria
- Researchers who provide a methodologically sound proposal.
All individual participant data defined in the protocol will be collected during trial participation and entered in a secured Electronic Data Capturing System. All data shared or copied shared will only occur after complete deidentification. Participant data will be made available for Annual Data Safety Management Board (DSMB) committee review. The Study Protocol, Informed Consent Form, and applicable Case Report Forms will be available.